The promises and challenges of epigenetic epidemiology

被引:17
作者
Michels, Karin B. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr,Dept Obstet Gyneco, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
Epigenetics; Epidemiology; DNA methylation; Genomic imprinting; Histone modification; Tissue-specificity; Confounding; Study design; DNA METHYLATION; TISSUE ADJACENT; GENE-EXPRESSION; RISK;
D O I
10.1016/j.exger.2009.12.011
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The union between epidemiology and epigenetics creates a new science that combines the strengths of both fields: the appropriate study design with adequate sample size to identify disease biomarkers and to uncover mechanistic pathways for environmental exposure and disease associations while controlling for confounding variables. Realization of the promises of epigenetic epidemiology requires overcoming some challenges in the design, conduct, and interpretation of epigenetic studies in human populations. These challenges include the choice of the appropriate tissue, confounding, misclassification, and effect modification. In particular, the tissue-specificity of epigenetic marks restricts epidemiologic studies of adequate size to easily accessible tissues. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:297 / 301
页数:5
相关论文
共 50 条
  • [21] Prospects for Epigenetic Epidemiology
    Foley, Debra L.
    Craig, Jeffrey M.
    Morley, Ruth
    Olsson, Craig J.
    Dwyer, Terence
    Smith, Katherine
    Saffery, Richard
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 (04) : 389 - 400
  • [22] Epigenetic Regulation and Measurement of Epigenetic Changes
    Stephens, Kimberly E.
    Miaskowski, Christine A.
    Levine, Jon D.
    Pullinger, Clive R.
    Aouizerat, Bradley E.
    [J]. BIOLOGICAL RESEARCH FOR NURSING, 2013, 15 (04) : 373 - 381
  • [23] Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises
    El-Araby, Amr M.
    Fouad, Abdelrahman A.
    Hanbal, Amr M.
    Abdelwahab, Sara M.
    Qassem, Omar M.
    El-Araby, Moustafa E.
    [J]. ARCHIV DER PHARMAZIE, 2016, 349 (02) : 73 - 90
  • [24] Epidrugs in the clinical management of atherosclerosis: Mechanisms, challenges and promises
    Panduga, Sushma
    Vasishta, Sampara
    Subramani, Ramamoorthy
    Vincent, Sthevaan
    Mutalik, Srinivas
    Joshi, Manjunath B.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 980
  • [25] Use of DNA methylation for cancer detection: Promises and challenges
    Zhu, Jingde
    Yao, Xuebiao
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (01) : 147 - 154
  • [26] Mendelian randomization: applications and limitations in epigenetic studies
    Relton, Caroline L.
    Smith, George Davey
    [J]. EPIGENOMICS, 2015, 7 (08) : 1239 - 1243
  • [27] Challenges and opportunities in targeting epigenetic mechanisms for pulmonary arterial hypertension treatment
    Feng, Jie
    Liu, Yunman
    Li, Kai
    Wu, Yanqing
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2025, 672
  • [28] Epigenetic Aberrations and Targeted Epigenetic Therapy of Esophageal Cancer
    Zhao, Ronghua
    Casson, Alan G.
    [J]. CURRENT CANCER DRUG TARGETS, 2008, 8 (06) : 509 - 521
  • [29] Epigenetics of Osteoporosis: Critical Analysis of Epigenetic Epidemiology Studies
    Riancho, Jose A.
    [J]. CURRENT GENOMICS, 2015, 16 (06) : 405 - 410
  • [30] Towards a Novel Frontier in the Use of Epigenetic Clocks in Epidemiology
    Martinez-Magana, Jose Jaime
    Hurtado-Soriano, Jorge
    Rivero-Segura, Nadia Alejandra
    Montalvo-Ortiz, Janitza L.
    Garcia-delaTorre, Paola
    Becerril-Rojas, Kristhian
    Gomez-Verjan, Juan Carlos
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2024, 55 (05)